tiprankstipranks
Trending News
More News >
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX

Royalty Pharma (RPRX) Revenue

Compare
1,298 Followers

Royalty Pharma Revenue

Royalty Pharma had a revenue of 609.29M in the quarter ending Sep 30, 2025, with 5.29%. This bring the company's revenue in the last twelve months to 2.35B, Decreased 1.93%. In the fiscal year ending Dec 31, 2024, Royalty Pharma had annual revenue of 2.26B with -3.86% growth.
Revenue (ttm)
2.35B
Revenue Growth
3.72%
P/S Ratio
9.84
Revenue/Employee
$30,181,013
Employees
75
Market Cap
$22.28B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.26B-90.98M+96.14%
Dec 31, 2023
2.35B117.34M+105.24%
Dec 31, 2022
2.24B-52.25M+97.72%
Dec 31, 2021
2.29B167.11M+107.87%
Dec 31, 2020
2.12B308.10M+116.98%
Dec 31, 2019
1.81B19.36M+101.08%
Dec 31, 2018
1.79B196.96M+112.33%
Dec 31, 2017
1.60B